Thus, although the prognostic potential of circulating MVs is still in its infancy, our findings indicate that detection and quantification of MV subpopulations, especially CD36+ MVs, may be a potentially valuable tool for risk assessment and may add to a better understanding of their potential contribution to vascular complications in hypercholesterolemia. Here, CD36 is linked to Hypercholesterolemia.